Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Current Deferred Tax Assets (2018 - 2020)

Avai Bio's Current Deferred Tax Assets history spans 3 years, with the latest figure at -$14078.0 for Q1 2020.

  • For Q1 2020, Current Deferred Tax Assets rose 15.1% year-over-year to -$14078.0; the TTM value through Mar 2020 reached -$14078.0, up 15.1%, while the annual FY2020 figure was -$14078.0, 15.1% up from the prior year.
  • Current Deferred Tax Assets for Q1 2020 was -$14078.0 at Avai Bio, up from -$16582.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at -$1301.6 in Q2 2018 and bottomed at -$16582.0 in Q1 2019.
  • The 3-year median for Current Deferred Tax Assets is -$14078.0 (2020), against an average of -$10653.9.
  • The largest YoY upside for Current Deferred Tax Assets was 15.1% in 2020 against a maximum downside of 15.1% in 2020.
  • A 3-year view of Current Deferred Tax Assets shows it stood at -$1301.6 in 2018, then tumbled by 1173.96% to -$16582.0 in 2019, then increased by 15.1% to -$14078.0 in 2020.
  • Per Business Quant, the three most recent readings for AVAI's Current Deferred Tax Assets are -$14078.0 (Q1 2020), -$16582.0 (Q1 2019), and -$1301.6 (Q2 2018).